baber/WOPTO huggingface dataset:
Patent CA-2670486-A1 (CA)
Title: Passive-active terminal adapter and method having automatic return loss control
Inventor: WELLS CHAD T
IPC: H04N17/04
Filed: 2009-06-26
Abstract: Return loss due to excessive signal reflection into a cable television (CATV) network from an inoperative or abnormally operative terminal adapter is minimized, to communicate enhanced passive downstream signals to passive subscriber devices such as "life-line" telephone sets. A predetermined termination impedance is substituted for an active branch circuit of the terminal adapter whenever reduced input voltage, over-current or under-current conditions exist in the terminal adapter.
Patent CA-2675113-A1 (CA)
Inventor: LEGRAND VERONIQUE
IPC: G06F21/57
Filed: 2008-01-11
Abstract: The invention relates to a method for monitoring at least one message, each message being associated with an action generated by at least one element or user of an information system (1000), said message(s) being collected by at least one message collecting device of the IS. According to the invention, the method comprises the step of defining a plurality of reference event categories each associated with at least one reference action from an ontology based on an intention class that characterises the purpose of each reference action, an activity type class that qualifies the nature of each reference action, a movement class that characterises the means for implementing each reference action, a target class that characterises the object of each reference action, and a gain class that characterises the result of each reference action.
Patent CA-2675724-A1 (CA)
Title: Oral extended-release composition
Inventor: BROWDER MONTE
IPC: A61K9/54
Filed: 2004-06-16
Abstract: The invention is directed to controlled release formulations containing drugs which are preferably considered sparingly soluble to insoluble and which are suitable for administration to a patient in need of treatment related thereto, and methods of manufacturing same.
Patent CA-2677489-A1 (CA)
Title: High performance foams for unloading gas wells
Inventor: YANG JIANG
IPC: E21B43/00
Filed: 2008-02-04
Abstract: Mixtures of at least one nonionic surfactants and at least one ionic surf actant together with a gas create foams to aid the removal of produced hydro carbon fluids from gas wells and pipelines. The foam-forming composition has superior performance in unloading liquids.
Patent CA-2678063-A1 (CA)
Inventor: BUJOLI BRUNO
IPC: A61K6/838
Filed: 2008-02-13
Abstract: The present invention relates to a macroporous, resorbable and injectable apatitic calcium-phosphate cement with a high compressive strength useful as bone cement and releasing a bone resorption inhibitor, preparation method and uses thereof.
Patent CA-2679614-A1 (CA)
Title: Endovascular deployment device
Inventor: HARTLEY DAVID ERNEST
IPC: A61F2/84
Filed: 2008-03-06
Abstract: An endovascular delivery device has a portion, such as the nose cone dilator (40), being formed from a radiopaque material and that portion has a selected transverse profile such as a notch through aperture (47) so that in a selected rotational orientation of the endovascular delivery device the nose cone dilator can be observed by radiographic means during an endovascular procedure to be in that selected rotational orientation. The selected transverse profile can be a notch, protrusion or aperture. The notch or aperture can be filled with a radio-transparent material to provide a smooth outer surface.
Patent CA-2681023-A1 (CA)
Inventor: MOLLER CLAUS SCHMIDT
IPC: A61M5/20
Filed: 2008-03-14
Abstract: The invention relates to an injection device for injecting a dose of drug. Theinjection device com prises a housing, a dose setting mechanism being operable to set a desired dose, an injection mechanism comprising a piston rod (7) adapted to cooperate with a piston positioned in a cartridge containing a drug to be delivered in order to cause a set dose to be delivered from the cartridge via the injection device, a dosage tube (6), and retaining means arranged to prevent axial movement of the dosage tube in a distal direction relatively to the housing during dose setting. The dose setting mechanism com prises a rotatable dose knob (24), operation of the dose setting mechanism causing energy to be stored in a spring member. The injection mechanism is driven by releasing energy previously stored in the spring member during dose setting.
Patent CA-2681921-A1 (CA)
Inventor: BROWN SUSAN ELIZABETH
IPC: A01N63/50
Filed: 2008-03-26
Abstract: The present invention relates to antifungal and/or antibacterial peptides, especially antifungal peptides obtained from insect species, particularly lepidopterans. The present invention also provides methods of using these antifungal peptides to treat or prevent fungal growth for a variety of purposes such as; protecting plants from fungal infections, treating fungal infections of animals, especially humans, and prevention of food spoilage.
Patent CA-2683641-A1 (CA)
Title: Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k alpha
Inventor: LAMB PETER
IPC: A61K31/337
Filed: 2008-04-09
Abstract: The present invention provides methods of treating cancer by administering a compound of Formula I, optionally as a pharmaceutically acceptable salt, solvate and/or hydrate thereof, in combination with other cancer treatments. (Formula I)
Patent CA-2685298-A1 (CA)
Inventor: MESHER SHAUN T E
IPC: C09K8/536
Filed: 2009-10-30
Abstract: A fracturing fluid for a downhole environment is disclosed, comprising a water-sensitive gel;  and a hydrated breaker. A fracturing fluid for a downhole environment is also disclosed, the fracturing fluid comprising a water-sensitive carrier and a breaker, the breaker comprising one or more hydrates, and wherein water of the one or more hydrates is releasable so as to act with the water-sensitive carrier to reduce the viscosity of the fluid. A  method of treating a downhole environment with a fracturing fluid is also disclosed, the method comprising:  providing to the downhole environment a fluid comprising a water-sensitive carrier and a breaker, the breaker comprising one or more hydrates; and allowing water from the one or more hydrates to release so as to act with the carrier to reduce the viscosity of the fluid.
Patent CA-2689740-A1 (CA)
Title: Biodegradable water bottle
Inventor: ANDREWS ANN
IPC: B65D65/46
Filed: 2010-01-05
Abstract: THE PURPOSE OF THIS APPLICATION IS TO IMPROVE ON  AN EXISTING INVENTION; AND TO PROVIDE THE WATER  COMPANIES AND ALL OTHER COMPANIES AND   INDIVIDUALS NEEDING DISPOSABLE BOTTLES WITH AN  ENVIROMENTALLY FRIENDLY WATER BOTTLE; MADE  FROM A PARTICULAR KIND OF BIODEGRADABLE  MATERIAL, A FORM OF PAPERBOARD AND  POLYETHLENE MIXTURE, OR ANY KIND OF  BIODEGRADABLE MATERIAL, WHICH IS NOT HARMFUL  TO HUMANS,OR THE ENVIROMENT AFTER IT'S USE.
Patent CA-2693210-A1 (CA)
Title: Building air filtration system
Inventor: BORDIN ANDREW
IPC: F24F13/28
Filed: 2010-02-17
Abstract: An air filter system and an air filter therefor are provided for use in a building with first and second zones separated by a wall-door system having a wall with a door therein. Weatherstripping is mounted between side and upper edges of the door and a door frame in the wall and between the lower edge of the door and the threshold region of the floor to substantially seal against air flow between the door edges and the door frame and floor when the door is closed. An air flow permitting opening is provided in the wall-door system, sized to permit a controlled amount of airflow between the first and second zones when there is a pre-determined pressure differential between said zones. An air filter is mounted in such opening.
Patent CA-2694259-A1 (CA)
Title: Ion conductor having a garnet structure
Inventor: WEPPNER WERNER
IPC: H01G11/30
Filed: 2008-07-02
Abstract: The present invention relates to the use of chemically stable solid ion conductors having a garnet-like structure in batteries, accumulators, electrochromic devices and other electrochemical cells and also new compounds which are suitable for these uses.
Patent CA-2696669-A1 (CA)
Inventor: BOONSTRA TJERK OEDSE
IPC: C11D3/33
Filed: 2008-08-14
Abstract: The present invention relates to an alkalimetal salt of glutamic acid-N,N-diacetic acid (GLDA) of the formula Na x K y H z GLDA, wherein x is equal to or more than 2 and lower than 4 and y is more than 0 and equal to or lower than 2, x+y is 3.5-4, and x+y+z = 4, to processes to prepare such salt and the use thereof.
Patent CA-2697126-A1 (CA)
Inventor: QIU RONGBIN
IPC: G08B25/00
Filed: 2010-03-18
Abstract: Property monitoring system and method of operating. Two signal lines are used to couple a master controller in series with a plurality of indicators. Each indicator has a visual display. Each visual display has a plurality of LEDs, or other type of lighting device. The master controller is configured to generate a multi-bit digital command message to be transmitted serially to the plurality of indicators over the second signal line upon receipt of an alarm condition message. Each command message has a predetermined time delay for activating each of the indicators, or a component thereof, so that all indicators activate in unison.
Patent CA-2697322-A1 (CA)
Inventor: BALK SVEN
IPC: C08F297/02
Filed: 2008-08-11
Abstract: The invention relates to a process for preparing CABAC or ACBCA pentablock copolymers based on (meth)acrylate with an OH functionalization of the A  blocks.
Patent CA-2698239-A1 (CA)
Inventor: GROBBELAAR WARREN
IPC: G09F11/12
Filed: 2008-09-12
Abstract: A display device which includes a housing, a plurality of separately movable indicators in the housing, each indicator including a plurality of symbols, an electrically operable actuator and a controller for controlling operation of the actuator whereby each indicator is independently movable to a selected position to display a selected symbol.
Patent CA-2703390-A1 (CA)
Inventor: BREMNES DAG
IPC: G06V30/224
Filed: 2008-10-23
Abstract: A method and system for analysis of immunoassays, and more specifically to an improved analysis of chromatographic assays, often referred to as a lateral flow assay is disclosed. These assays commonly employ a test strip utilizing visible particles as the labels for the analytes to be detected, where, as an additional feature, the analytical strip is removable for reading the quantity of analytes captured therein and for archival purposes. An image of the test strip is analysed automatically.
Patent CA-2705735-A1 (CA)
Inventor: CHEN MICHAEL M
IPC: B02C15/02
Filed: 2008-11-14
Abstract: A roller mill 10 for pulverizing fine material has a grinding mechanism that includes a plurality of grinding rolls 64 and a grinding ring 66 that coact to pulverize material within a mill housing. The grinding ring has an inner grinding surface wherein the inner surface includes an upper vertical portion and inwardly sloped lower portion. The lower portion of the ring provides a means for retaining more fine particles on the ring during pulverizing, as well as an increase in grinding surface. The grinding rolls have a generally cylindrical shape with an outer grinding surface that includes an upper vertical portion and a lower portion of the outer grinding surface. The outer grinding surface of the roll is complementary to the inner grinding surface of the grinding ring.
Patent CA-2707349-A1 (CA)
Title: Organic compounds useful as inhibitors of phosphodiesterase 1
Inventor: LI PENG
IPC: C07D491/00
Filed: 2008-12-06
Abstract: 1- or 2-substituted (6aR,9aS)-3-(phenylamino)-5-6a,7,8,9,9a-hexahydro-5-methyl-cyclopent[4,5]imi-dazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(1H or, 2H)-one compounds of Formula (I), processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.
Patent CA-2708043-A1 (CA)
Title: Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-fluoro-4- (pyrrolidin-1-yl-methyl) -phenyl] cyclobut anecarboxamide
Inventor: WAGER TRAVIS T
IPC: C07D295/073
Filed: 2008-12-04
Abstract: The present invention is directed to the tosylate salt of trans-N-isobutyl- 3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-yl-methyl)-phenyl]-cyclobutanecarboxamide Formula (1): to solvates (e.g., hydrates) thereof, to polymorphs thereof, to pharmaceutical compositions thereof and to a method of treating depression, mood disorders, schizophrenia, anxiety disorders, cognitive disorders, Alzheimer's disease, attention-deficit disorder (ADD), attention-deficit hyperactivity disorder (ADHD), psychotic disorders, sleep disorders, obesity, dizziness, epilepsy, motion sickness, respiratory diseases, allergy, allergy-induced airway responses, allergic rhinitis, nasal congestion, allergic congestion, congestion, hypotension, cardiovascular disease, diseases of the G1 tract, hyper- and hypo-motility and acidic secretion of the gastro-intestinal tract comprising administering a therapeutically effective amount thereof.
Patent CA-2710357-A1 (CA)
Inventor: TENG WEI-CHE
IPC: B29D11/00
Filed: 2010-07-26
Abstract: This invention relates to an eyeglass die without frame groove for lens and eyeglass made by the same, the die including a stationary die and a movable die with an eyeglass configuration provided therein. In the stationary die, stationary posts for locating the lens are provided on the upper and lower portions of runner for the eyeglass frame. Regions for disposing the lenses in the stationary die and the movable die are formed with annular flanges which cooperate to clamp the lenses in right place and to form a blocking wall. In this way, a hollow-out is formed in the region for disposing the lenses so as to protect the same, while the blocking wall and the runner are for producing an eyeglass having lenses integrally embedded therein by injection molding.
Patent CA-2715367-A1 (CA)
Inventor: BACHAND CAROL
IPC: C07D403/14
Filed: 2008-02-12
Abstract: The present disclosure relates to (4-4' -diimidazolyl) biphenyls compositions and methods for the treatment of hep-atitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for us-ing these compounds in the treatment of HCV infection.
Patent CA-2716125-A1 (CA)
Inventor: WARREN RAPHAEL
IPC: A61L15/34
Filed: 2009-02-23
Abstract: An absorbent article comprises a lotion composition comprising a particular cooling agent. In one embodiment, the cooling agent comprises a particular N-substituted p-menthane carboxamide material. In another embodiment, the cooling agent comprises a cooling material having an enthalpy of vaporization of at least 71 kJ/mol at 760 Torr. The absorbent articles comprising the particular cooling agents provide a cooling sensation to the skin of the wearer of the absorbent article.
Patent CA-2719705-A1 (CA)
Inventor: GREGORY CHRISTOPHER
IPC: A61F5/445
Filed: 2009-04-21
Abstract: A temporary ostomy appliance is disclosed, including a catheter for extending through the abdominal wall into the intestine. The catheter may be a transcecal catheter for extending through the cecal valve into the ileum. A portion of a catheter that extends through the cecal valve is made collapsible when the catheter is empty. The collapsed portion expands to permit passage of effluent. A balloon carried on the catheter is preformed with a shape and size in order to permit inflation without elastic stretching of the balloon wall material. A filament is provided for permitting a portion of the catheter to be fastened to internal body tissue by surgical sutures or staples. In order to release the fastening without further surgery, the filament is withdrawn by pulling on a proximal portion outside the body.
Patent CA-2720946-A1 (CA)
Inventor: CHEN BEI
IPC: A61P35/00
Filed: 2009-04-03
Abstract: The invention pro-vides novel pyrimidine derivatives and pharmaceutical compositions thereof, and methods for using such compounds. For example, the pyrimi-dine derivatives of the invention may be used to treat, ameliorate or prevent a condition which responds to inhibi-tion of anaplastic lymphoma kinase (ALK) activity, c-ros oncogene (ROS), insulin-like growth factor (IGF-1R), and/or insulin receptor (InsR) or a combination thereof.
Patent CA-2723831-A1 (CA)
Title: Iso-pressure open refrigeration ngl recovery
Inventor: MALSAM MICHAEL
IPC: F25J3/00
Filed: 2009-04-30
Abstract: The present invention relates to an improved process for recovery of natural gas liquids from a natural gas feed stream. The process runs at a constant pressure with no intentional reduction in pressure. An open loop mixed refrigerant is used to provide process cooling and to provide a reflux stream for the distillation column used to recover the natural gas liquids. The processes may be used to recover C3+ hydrocarbons from natural gas, or to recover C2+ hydrocarbons from natural gas.
Patent CA-2724010-A1 (CA)
Title: Systeme de ventilation de toit resistant aux braises et resistant aux flammes
Inventor: DANIELS GREGORY S
IPC: F24F13/06
Filed: 2009-05-13
Abstract: L'invention porte sur des systèmes de ventilation, plus particulièrement sur des systèmes de ventilation de toit, qui aident à protéger des bâtiments vis-à-vis d'incendies. L'exutoire de fumée comprend une structure de blocage de braise qui empêche l'entrée de flammes et de braises ou autres matériaux de combustion flottants tout en permettant un écoulement d'air suffisant pour ventiler de manière adéquate un bâtiment. Plusieurs configurations d'exutoires employant des éléments de déviation et un matériau en treillis résistant aux incendies sont décrits, lesquels peuvent empêcher sensiblement l'entrée de braises flottantes et de flammes.
Patent CA-2724198-A1 (CA)
Inventor: STEVANOVIC STEFAN
IPC: C07K14/47
Filed: 2009-05-14
Abstract: The present invention relates to peptides, nucleic acids, and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to survivin-derived tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention specifically relates to three novel peptide sequences and variants thereof derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
Patent CA-2726626-A1 (CA)
Inventor: BUCHWALD ROBERT
IPC: B64G1/22
Filed: 2011-01-04
Abstract: A pivotal connection and a substantially rigid yet disruptable mechanical connection mount a respective foot pad on a distal end of each one of plural landing legs of a lander spacecraft. The mechanical connection includes at least one predetermined rated breaking point designed to break when the foot pad makes contact with a landing ground surface. At least two sensor elements, preferably electrical conductors or switches, are incorporated in the mechanical connection(s) of one or more foot pads. When the foot pad makes ground contact, the mechanical connection breaks at the rated breaking point(s), which also disrupts or actuates the sensor element(s), which thus provides a signal to an evaluating unit, which triggers the shut-down of at least one braking retrorocket or retrothruster.
Patent CA-2732628-A1 (CA)
Inventor: BABU YARLAGADDA S
IPC: A61K31/53
Filed: 2009-07-31
Abstract: The invention provides a compound of formula (1):wherein W is a bicyclic heteroaromatic group; or a salt thereof.  The compounds and salts thereof have beneficial therapeutic properties (e.g.  immunosuppressant properties).
Patent CA-2732887-A1 (CA)
Inventor: BEATTIE DAVID
IPC: A61K31/427
Filed: 2009-08-05
Abstract: There are described cyclohexyl amide derivatives useful as corticotropin releasing factor (CRF1) receptor antagonists.
Patent CA-2733312-A1 (CA)
Inventor: HENDERSHOT REED JACOB
IPC: F27D7/00
Filed: 2011-03-02
Abstract: A method of combustion and a reformer. The method includes combusting a fuel in a combustion region of an up-fired or down-fired reformer and forming non-uniform injection properties with a wall-bound burner. The combusting is performed in a combustion region by burners, wherein at least one of the burners is the wall-bound burner forming the non-uniform injection properties. The non-uniform injection properties generate a heat profile providing a first heat density proximal to a wall and a second heat density distal from the wall, the second heat density being greater than the first heat density. The non-uniform injection properties are formed by injection properties selected from an angle of one or more injectors, a flow rate of one or more injectors, an amount and/or location of oxidant injectors, an amount and/or location of fuel injectors, and combinations thereof.
Patent CA-2733528-A1 (CA)
Title: Catalyst for the decomposition of lignin, method for the preparation of alcohols and organic acids, method for the preparation of lignin-decomposition products, catalyst for the decomposition of aromatic hydrocarbons, method for releasing hydrogen ions, as well as porphyrin
Inventor: ISHIBASHI TORU
IPC: C07C27/00
Filed: 2009-08-11
Abstract: Herein provided are a lignin-decomposition catalyst and an aromatic hydrocarbon-decomposition catalyst, which contain a porphyrin. Alcohols and organic acids can be isolated or separated from lignin by adding a solution containing an alkaline compound to lignin, optionally acting a lignin-decomposition catalyst on the resulting lignin-alkaline compound-containing solution and optionally irradiating, with light rays, the solution; or by optionally acting a lignin- decomposition catalyst on lignin and then irradiating it with light rays. The decomposition products generated during the isolation of the foregoing alcohols and organic acids are recovered and hydrogen ions are released from lignin. Herein provided also include a porphyrin having such a catalytic function that it can convert lignin into alcohols and organic acids; a porphyrin having such a catalytic function that it can decompose a compound containing an aromatic hydrocarbon in which an oxygen is linked to a carbon atom constituting the benzene ring thereof; and a porphyrin obtained by cultivating Escherichia coli which cannot express the gene: ypjD (b2611) due to the variation thereof.
Patent CA-2736528-A1 (CA)
Inventor: JAFARI MEHDI
IPC: A61B5/085
Filed: 2009-09-22
Abstract: Systems and methods for efficient computation of patient respiratory muscle effort are provided. According to one embodiment, patient-ventilator characteristics are received, estimated and/or measured representing values of parameters of interest associated with properties or attributes of a ventilated patient system.  Online quantification of respiratory muscle effort of the patient is continuously performed by (i) establishing a respiratory predictive model of the ventilated patient system based on an equation of motion and functions that approximate clinically-observed, patient-generated muscle pressures, (ii) determining an instantaneous leak flow value for the ventilated patient system, and (iii) based on the patient-ventilator characteristics and the instantaneous leak flow value, solving the respiratory predictive model to extract an estimated physiologic respiratory muscle effort value. Then, based on the respiratory muscle effort value or other parameters derived therefrom, the ventilation system is configured and operated for monitoring or breath delivery purposes.